What is Idexx Laboratories's G&A?

Idexx Laboratories (IDXX) reported G&A of $119.12M in Q1 2026.

How has Idexx Laboratories's G&A changed year-over-year?

Idexx Laboratories's G&A increased by 30.1% year-over-year, from $91.56M to $119.12M.

What is the long-term trend for Idexx Laboratories's G&A?

Over 4 years (2021 to 2025), Idexx Laboratories's G&A has grown at a 6.9% compound annual growth rate (CAGR), from $309.66M to $404.79M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Idexx Laboratories IDXX G&A

G&A at other companies

NeogenNEOG

$60.3M+8.1%

VeracyteVCYT

$23.68M-30.0%

Insight Molecular Diagnostics Inc.IMDX

$2.99M-4.0%

Other financials

Income statement

See full

Revenue$1.1B+14.3%

Gross profit$722.7M+15.9%

Operating income$362.6M+14.5%

Net income$278.4M+14.7%

EPS (diluted)$3.47+17.2%

Balance sheet

See full

Cash & equivalents$200.5M+22.3%

Total debt$575.5M-22.2%

Total equity$1.6B+7.5%

Total assets$3.4B+5.3%

Cash flow

See full

Operating cash flow$266.2M+11.9%

CapEx$32.0M+6.5%

Free cash flow$234.3M+12.7%

Valuation

See full

Market cap$44.93B-2.5%

Enterprise value$45.3B-2.7%

P/E41×-5.7×

P/S10.1×-1.3×

Profitability

See full

Gross margin62.1%+0.8pp

Operating margin31.6%+2.5pp

Net margin24.6%+1.9pp

FCF margin24.4%+2.8pp

Returns & leverage

See full

Return on equity72.9%+13.6pp

Debt / equity0.4×-0.1×

Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Idexx Laboratories's G&A?: Idexx Laboratories (IDXX) reported G&A of $119.12M in Q1 2026.
How has Idexx Laboratories's G&A changed year-over-year?: Idexx Laboratories's G&A increased by 30.1% year-over-year, from $91.56M to $119.12M.
What is the long-term trend for Idexx Laboratories's G&A?: Over 4 years (2021 to 2025), Idexx Laboratories's G&A has grown at a 6.9% compound annual growth rate (CAGR), from $309.66M to $404.79M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.